ENTO
Entero Therapeutics
ENTO
ENTO
17 hedge funds and large institutions have $10.1M invested in Entero Therapeutics in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GGHC
1
Gilder Gagnon Howe & Co
New York
|
$1.78M |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$1.74M |
| 3 |
6CM
3
683 Capital Management
New York
|
$1.28M |
| 4 |
HCM
4
Highbridge Capital Management
New York
|
$1.01M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.3M |
Top Sellers
| 1 |
IWM
1
IHT Wealth Management
Chicago,
Illinois
|
$0 |
